Hypothesis

5 Matching Annotations

Dec 2025
www.sciencedirect.com:5037 www.sciencedirect.com:5037

Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy

1
1. scibot 10 Dec 2025
  
  in Public
  
  RRID:AB_2563881
  
  DOI: 10.1016/j.cell.2025.11.015
  
  Resource: (BioLegend Cat# 502536, RRID:AB_2563881)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563881
  
  What is this?
  
  RRID:AB_2563881
Visit annotations in context

Tags

RRID:AB_2563881

Annotators

scibot

URL

sciencedirect.com:5037/science/article/pii/S009286742501311X
Sep 2025
www.sciencedirect.com www.sciencedirect.com

Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carcinoma

1
1. scibot 17 Sep 2025
  
  in Public
  
  RRID:AB_2563881
  
  DOI: 10.1016/j.xcrm.2025.102360
  
  Resource: (BioLegend Cat# 502536, RRID:AB_2563881)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563881
  
  What is this?
  
  RRID:AB_2563881
Visit annotations in context

Tags

RRID:AB_2563881

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125004331
Jul 2025
www.cell.com www.cell.com

Immune profiling in subclinical secondary dengue-infected cases reveals adaptive immune signatures correlated to protection from severe dengue

1
1. scibot 11 Jul 2025
  
  in Public
  
  RRID:AB_2563881
  
  DOI: 10.1016/j.chom.2025.06.006
  
  Resource: (BioLegend Cat# 502536, RRID:AB_2563881)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563881
  
  What is this?
  
  RRID:AB_2563881
Visit annotations in context

Tags

RRID:AB_2563881

Annotators

scibot

URL

cell.com/cell-host-microbe/abstract/S1931-3128(25)00235-5
Nov 2022
www.sciencedirect.com www.sciencedirect.com

Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy

1
1. scibot 16 Nov 2022
  
  in Public
  
  RRID:AB_2563881
  
  DOI: 10.1016/j.celrep.2022.111647
  
  Resource: (BioLegend Cat# 502536, RRID:AB_2563881)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563881
  
  What is this?
  
  RRID:AB_2563881
Visit annotations in context

Tags

RRID:AB_2563881

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124722015182
Oct 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

1
1. scibot 27 Oct 2022
  
  in Public
  
  RRID:AB_2563881
  
  DOI: 10.1016/j.xcrm.2022.100783
  
  Resource: (BioLegend Cat# 502536, RRID:AB_2563881)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2563881
  
  What is this?
  
  RRID:AB_2563881
Visit annotations in context

Tags

RRID:AB_2563881

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9589122/